UK harm-reduction overview

Risks & Safety

Ibogaine has serious, potentially life-threatening risks. This page sets out what is known about cardiac effects, interactions, psychiatric complications, screening limits, and urgent warning signs—without presenting ibogaine as established or risk-free treatment.

Information for people in the UK considering ibogaine or supporting someone affected by substance use. It is not clinical or legal advice.

Close-up image accompanying an evidence-focused overview of ibogaine safety and risk — Safety before claims

01 / What is at stake

A psychoactive substance with a narrow margin for error

Ibogaine is a psychoactive alkaloid associated with the iboga plant. It is commonly discussed in relation to substance use, but it is not a routine, established treatment in the UK. Its effects can be prolonged and unpredictable, particularly where health conditions, prescribed medicines, or other substances are involved. The wider context—including questions of law and access—is set out in this site’s UK ibogaine guidance.

Ibogaine and its metabolite noribogaine affect several signalling systems. A key safety concern is their potential effect on cardiac electrical activity, including QT interval prolongation. The National Center for Biotechnology Information overview of long QT syndrome explains why disturbances in cardiac repolarisation can matter: in some circumstances, they can increase the risk of dangerous arrhythmias.

Cardiac effects

Known concerns include QT prolongation, bradycardia, fainting, and potentially dangerous rhythm changes.

Metabolism

Liver function and medicine metabolism may affect exposure, persistence, and interaction risk.

Acute stress

Vomiting, dehydration, electrolyte imbalance, and acute illness can compound medical risk.

Psychological strain

Intense perceptual and emotional effects can be destabilising, especially for vulnerable people.

02 / Evidence and uncertainty

Reported adverse events deserve direct attention

Published case reports and reviews have described severe adverse events, including cardiac arrhythmias and deaths, in connection with ibogaine exposure. Reports can be incomplete and often involve more than one possible factor, but uncertainty is not reassurance. It is a reason to avoid simple claims of safety.

The medical literature has repeatedly highlighted cardiac toxicity as a concern, while the general pharmacology of ibogaine also reflects the need for caution around its psychoactive effects and regulatory status. No screening process can remove every risk, and an apparently uncomplicated past exposure does not predict a safe future exposure.

Risks may rise when there is pre-existing heart disease, a personal or family history of sudden cardiac death, low potassium or magnesium, liver impairment, dehydration, use of multiple substances, or medicines that affect heart rhythm or serotonin. A careful discussion of practical, evidence-based support options is available through the site’s alternatives and support pathway.

Quiet landscape image accompanying discussion of ibogaine adverse events and evidence uncertainty

03 / Screening limits

What careful pre-screening would need to consider

People sometimes treat “screening” as a safety guarantee. It is not. The following elements are commonly relevant to assessing avoidable risk, but this is informational only and not a protocol, clearance, or substitute for assessment by qualified clinicians. Where someone is considering a decision with legal consequences, they should also seek appropriate legal advice.

ECG and cardiac history: consideration of QT interval, rhythm findings, structural heart disease, fainting, palpitations, and family history of sudden death.
Medicines and substances: a full review of prescribed medicines, over-the-counter products, supplements, alcohol, stimulants, opioids, and other drugs—especially agents that can affect rhythm, serotonin, or metabolism.
Blood and liver measures: consideration of electrolytes, liver function, kidney function, hydration, acute infection, and other signs of physiological stress.
Psychiatric history: attention to previous psychosis, mania, severe dissociation, suicidality, trauma-related instability, and current mental health symptoms.

Important: Existing health information can be incomplete, test results can change, and dangerous interactions are not always obvious. This page does not endorse self-assessment or treatment outside qualified medical care.

04 / Key decision points

Where risk may be particularly difficult to justify

A / Cardiac

Heart or rhythm concerns

A history of arrhythmia, unexplained collapse, structural heart disease, prolonged QT, or a concerning family history calls for professional assessment rather than assumptions.

B / Medicines

Complex interactions

Medication changes or abrupt stopping can themselves be harmful. Interaction review should be led by a qualified prescriber or pharmacist, not online lists alone.

C / Mental health

Psychiatric instability

Prior psychosis, bipolar-spectrum symptoms, severe anxiety, or current crisis can increase the potential for acute psychological complications and impaired judgement.

05 / Urgent action

Emergency signs are not something to monitor at home

If someone has taken ibogaine or an unknown substance and develops urgent symptoms, call 999 for an ambulance or go to A&E. Be direct about what may have been taken, when it was taken, and any medicines or other substances involved. Do not leave someone alone if they are fainting, confused, severely agitated, or having breathing difficulties.

For non-emergency health advice in England, NHS 111 can help direct people to appropriate urgent care. If substance use is part of the situation, local drug and alcohol services or a GP may also be appropriate once immediate danger has passed.

Chest pain, fainting, collapse, or an irregular / racing heartbeat
Seizure, severe confusion, unresponsiveness, or marked agitation
Difficulty breathing, blue or grey lips, or repeated vomiting with weakness
New suicidal thoughts, psychosis, or behaviour that creates immediate danger

Short answers

Questions worth asking before accepting a claim

Can ibogaine be assumed safe with a normal ECG?

No. An ECG is one part of risk assessment, not a guarantee of safety. Medication exposure, electrolytes, liver function, cardiac history, dose, supervision, and acute illness can all matter.

What should happen if someone develops concerning symptoms?

Chest pain, fainting, seizure, severe confusion, breathing difficulty, or a racing or irregular heartbeat require urgent assessment. In the UK, call 999 or attend A&E in an emergency.

Is this page medical or legal advice?

No. It is independent information for harm reduction. It does not endorse treatment or replace advice from qualified clinicians or legal advisers. For wider questions about how this resource approaches uncertainty, see the principles behind this guidance.

Where can someone look for safer support?

Evidence-based help can include NHS services, specialist alcohol and drug support, mental health care, and peer or family support where appropriate. Cost may be a practical concern, but it should never displace safety; context around ibogaine treatment costs does not turn an unregulated or unsafe situation into a safe one.

A careful next step

Choose qualified support over certainty claims.

Where substance use, mental health, or immediate safety are involved, seek help from appropriate NHS, emergency, and specialist services. Do not rely on this page alone to make a medical or legal decision.

Explore support options